equip wnv (previously duvaxyn wnv)
zoetis belgium sa - inaktivert west nile virus, stamme vm-2 - immunologier for hovdyr - hester - for den aktive vaksinering av hestene til seks måneders alder eller eldre mot west-nile-virus sykdom ved å redusere antall hester viraemic.
proteq west nile
boehringer ingelheim vetmedica gmbh - west nile rekombinant canarypox virus (vcp2017 virus) - immunologicals for dyr av hestefamilien, hest, immunologicals - hester - aktiv immunisering av hester fra fem måneder mot vest-nile-sykdommen ved å redusere antall viraemiske hester. hvis kliniske tegn er tilstede, reduseres deres varighet og alvorlighetsgraden.
covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaksiner - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaksiner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
zoonotic influenza vaccine seqirus
seqirus s.r.l. - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - vaksiner - active immunisation against h5 subtype of influenza a virus.
focetria
novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/california/7/2009 (h1n1)-derived strain used nymc x-181 - influenza, human; immunization; disease outbreaks - influensavacciner - profylakse av influensa forårsaket av a (h1n1v) 2009 virus. focetria bør brukes i samsvar med offisielle veiledning.
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - influensavirusoverflateantigener (hemagglutinin og neuraminidase) av stamme a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaksiner - aktiv immunisering mot h5n1 subtype av influensa a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
jcovden (previously covid-19 vaccine janssen)
janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vaksiner - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger.
gumbohatch
laboratorios hipra, s.a. - levende svekket smittsomme bursal disease virus (ibdv), belastning 1052 - immunologicals for aves, innenlandske fugler, live viral vaksiner, avian smittsomme bursal disease virus (gumboro sykdom) - chicken; embryonated chicken eggs - for aktive vaksinering av 1-dag-gamle broiler unger og embryonated broiler kylling egg for å redusere kliniske tegn og lesjoner i bursa av fabricius forårsaket av svært virulente avian smittsomme bursal sykdom virus infeksjon.
vaxzevria (previously covid-19 vaccine astrazeneca)
astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vaksiner - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger.